Estradiol 3-saccharinylmethyl ether: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 22: | Line 22: | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Oximes]] | [[Category:Oximes]] | ||
== Estradiol_3-saccharinylmethyl_ether == | |||
<gallery> | |||
File:Saccharinylmethylestradiol.svg|Saccharinylmethylestradiol | |||
</gallery> | |||
Latest revision as of 20:46, 16 March 2025
Estradiol 3-saccharinylmethyl ether is a synthetic, steroidal estrogen that was studied in the 1970s but was never marketed. It is an estrogen ether – specifically, an ether of estradiol – and is described as a long-acting estrogen. The compound is related to other estrogens like estradiol, estradiol benzoate, and estradiol dipropionate.
Chemistry[edit]
Estradiol 3-saccharinylmethyl ether, also known as estradiol 3-(O-carboxymethyl)oxime ether, is a synthetic estrane steroid and a derivative of estradiol. It is more specifically a derivative of estradiol with a saccharinylmethyl ether at the C3 position and an oxime at the C17 position.
Pharmacology[edit]
As an estrogen, estradiol 3-saccharinylmethyl ether has the ability to bind to and activate the estrogen receptor (ER). It has been found to have high affinity for the ER and to be a potent and long-acting estrogen.
History[edit]
Estradiol 3-saccharinylmethyl ether was first described in the literature in 1971. It was studied in animals and was found to have a prolonged duration of action relative to that of estradiol itself. However, the compound was never marketed.
See also[edit]
Estradiol_3-saccharinylmethyl_ether[edit]
-
Saccharinylmethylestradiol
